Morning Buzz: KaloBios (KBIO), Can-Fite BioPharma (CANF), (AMZN), Apple (AAPL), eFuture Information Technology (EFUT)

KaloBios Pharmaceuticals, Inc. (KBIO) is up as much as 77% to $46.97 in pre-market trade on Friday after its CEO tweeted: “I spoke with my counsel & advisers and decided to stop lending my KBIO shares out until I better understand the advantages of doing so.” KaloBios has now seen its value surge by 2,500% in just a few days. The spike began on Nov. 19, when biotech investor Martin Shkreli announced a stake in the near-bankrupt biotechnology company. Shares were trading at less than 50 cents until couple of weeks ago.

Shares of Can-Fite BioPharma Ltd. (CANF) are higher by nearly 17% to $3.93 in pre-market trading on Friday following the company’s financial results for the nine months ended September 30, 2015 and updates on its drug development programs.

Shares of, Inc. (AMZN) were up slightly this morning on a Bloomberg report that the e-commerce giant might soon let viewers of its Prime Instant Video service to use other networks.

Apple Inc (AAPL) – TechChrunch details news that Cupertino has acquired “Faceshift”, a Swiss real-time motion capture startup that works on developing technology to create animated avatars and other figures that generate facial expressions that look human-like. Faceshift was used in the latest ‘Star Wars’ movie.

eFuture Information Technology Inc. (EFUT) shares spiked 154% to $20.75 in pre-market trading. With no specific news to account for the move, the strength is being attributed to Wednesday’s filing of 50.51% stake by Shiji (Hong Kong) Limited.

Disclaimer: This page contains affiliate links. If you choose to make a purchase after clicking a link, we may receive a commission at no additional cost to you. Thank you for your support!

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.